TY  - JOUR
AU  - Garcia, Concepcion
AU  - Gomez-Cañas, Maria
AU  - Burgaz, Sonia
AU  - Palomares, Belen
AU  - Gomez-Galvez, Yolanda
AU  - Palomo-Garo, Cristina
AU  - Campo, Sara
AU  - Ferrer-Hernandez, Joel
AU  - Pavicic, Carolina
AU  - Navarrete, Carmen
AU  - Luz Bellido, M
AU  - Garcia-Arencibia, Moises
AU  - Ruth Pazos, M
AU  - Muñoz, Eduardo
AU  - Fernandez-Ruiz, Javier
PY  - 2018
DO  - 10.1186/s12974-018-1060-5
UR  - http://hdl.handle.net/10668/12019
T2  - Journal of neuroinflammation
AB  - Neuroprotection with cannabinoids in Parkinson's disease (PD) has been afforded predominantly with antioxidant or anti-inflammatory cannabinoids. In the present study, we investigated the anti-inflammatory and neuroprotective properties of VCE-003.2,...
LA  - en
PB  - BMJ Open
KW  - Cannabinoids
KW  - Inflammation
KW  - LPS
KW  - Microglial activation
KW  - PPARγ receptors
KW  - Parkinson’s disease
KW  - VCE-003.2
KW  - Animals
KW  - Binding sites
KW  - Cannabinoids
KW  - Cell line
KW  - Humans
KW  - Inflammation
KW  - Male
KW  - Mice
KW  - Mice, inbred C57BL
KW  - Microglia
KW  - Neurons
KW  - Neuroprotective agents
KW  - PPAR gamma
KW  - Parkinsonian disorders
KW  - Quinones
TI  - Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
TY  - research article
VL  - 15
ER  -